share_log

Eli Lilly and Co | 4: Statement of changes in beneficial ownership of securities-Director Sulzberger Gabrielle

SEC announcement ·  Feb 21 16:32
Summary by Moomoo AI
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of the company's common stock on February 20, 2024. The transaction involved the acquisition of 13 shares at a price of $755.66 per share. Following this transaction, Sulzberger's direct holdings in Eli Lilly and Co increased to a total of 2,098 shares. The transaction is classified as a grant, award, or other acquisition, according to the transaction code description provided.
Gabrielle Sulzberger, associated with Eli Lilly and Co (LLY), completed a purchase of the company's common stock on February 20, 2024. The transaction involved the acquisition of 13 shares at a price of $755.66 per share. Following this transaction, Sulzberger's direct holdings in Eli Lilly and Co increased to a total of 2,098 shares. The transaction is classified as a grant, award, or other acquisition, according to the transaction code description provided.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more